TYRA BIOSCIENCES INC (TYRA) Stock Earnings & Estimates
USA - NASDAQ:TYRA - US90240B1061 - Common Stock
15.48 USD
+0.35 (+2.31%)
15.48 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 790.01% | N/A 159.84% | N/A 94.55% | N/A 104.08% | N/A 66.52% | |||||||
| EBITDA YoY % growth | -3.11M | -9.25M -197.43% | -26.15M -182.70% | -58.63M -124.21% | -79.592M -35.75% | -103.658M -30.24% | N/A -28.21% | N/A -10.48% | N/A -28.50% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -3.12M | -9.3M -198.08% | -26.29M -182.69% | -58.93M -124.15% | -79.945M -35.66% | -104.177M -30.31% | N/A -30.21% | N/A -17.06% | N/A -10.38% | N/A 15.33% | N/A 46.59% | N/A 159.11% | N/A 727.40% | N/A 128.17% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -1.33 4.36% | -1.61 -21.05% | -1.51 6.21% | N/A -34.34% | N/A -9.43% | N/A -3.85% | N/A 51.55% | N/A 170.32% | N/A 431.17% | N/A 126.04% | N/A 71.07% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.55 -27.20% | -0.58 -23.40% | -0.58 -23.70% | -0.62 -24.44% | -0.63 -15.62% |
| Revenue Q2Q % growth | |||||
| EBITDA Q2Q % growth | -35.598M -21.81% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -33.867M -13.86% | -36.022M -13.10% | -37.83M -20.28% | -40.538M -19.70% | -41.89M -23.69% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.50 -21.95% | -0.51 | 0.01 | 1.47% |
| Q2 2025 Q2Q % growth | -0.47 -46.87% | -0.54 | 0.07 | 12.85% |
| Q1 2025 Q2Q % growth | -0.47 -34.29% | -0.50 | 0.03 | 5.89% |
| Q4 2024 Q2Q % growth | -0.43 18.87% | -0.49 | 0.06 | 12.26% |
| Q3 2024 Q2Q % growth | -0.41 16.33% | -0.41 | 0.00 | -0.82% |
| Q2 2024 Q2Q % growth | -0.32 -3.23% | -0.42 | 0.10 | 23.17% |
| Q1 2024 Q2Q % growth | -0.35 -25.00% | -0.46 | 0.11 | 24.61% |
| Q4 2023 Q2Q % growth | -0.53 -70.97% | -0.49 | -0.04 | -8.10% |
| Q3 2023 Q2Q % growth | -0.49 -63.33% | -0.36 | -0.13 | -36.22% |
| Q2 2023 Q2Q % growth | -0.31 13.89% | -0.35 | 0.04 | 11.57% |
| Q1 2023 Q2Q % growth | -0.28 22.22% | -0.37 | 0.09 | 25.00% |
| Q4 2022 Q2Q % growth | -0.31 -29.17% | -0.37 | 0.06 | 15.58% |
| Q3 2022 Q2Q % growth | -0.30 58.33% | -0.42 | 0.12 | 27.82% |
| Q2 2022 Q2Q % growth | -0.36 | -0.32 | -0.04 | -11.45% |
| Q1 2022 Q2Q % growth | -0.36 | -0.20 | -0.16 | -76.47% |
| Q4 2021 Q2Q % growth | -0.24 | -0.21 | -0.03 | -12.04% |
| Q3 2021 Q2Q % growth | -0.72 | -0.30 | -0.42 | -143.41% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 8.51% | 0% | 6.08% |
| Revenue | N/A | N/A | N/A | N/A |